Edition:
United Kingdom

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

17.74HKD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
HK$17.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,516,674
52-wk High
HK$18.70
52-wk Low
HK$9.22

Select another date:

Mon, Feb 12 2018

BRIEF-CSPC Pharmaceutical Group Announces Drug Registration Approval Of "Paclitaxel For Injection (Albumin-Bound)"

* ‍"PACLITAXEL FOR INJECTION (ALBUMIN-BOUND)" GRANTED DRUG REGISTRATION APPROVAL BY CHINA FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:

BRIEF-CSPC Pharmaceutical Group's Gastric Cancer Drug Granted Orphan-Drug Designation By U.S. FDA​

* ‍GROUP'S GASTRIC CANCER DRUG "DP303C" WAS GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FDA​ Source text for Eikon: Further company coverage:

BRIEF-CSPC Pharmaceutical Group Says Unit's Listing Application To CSRC Was Accepted

* CSPC XNW SUBMITTED APPLICATION TO CSRC FOR PROPOSED A SHARE LISTING ON CHINEXT OF SZSE & RECEIVED NOTICE OF ACCEPTANCE

BRIEF-CSPC Pharmaceutical Group Appoints ‍Li Chunlei As Executive Director ​

* ‍LI CHUNLEI WAS APPOINTED AS AN EXECUTIVE DIRECTOR OF COMPANY WITH EFFECT FROM 12 DECEMBER 2017.​

BRIEF-CSPC Pharmaceutical Group announces change of shareholdings of substantial shareholder

* ‍Massive Giant Group transferred approximately 6.78% of total issued shares to Common Success International​ Source text for Eikon: Further company coverage:

BRIEF-CSPC Pharmaceutical Group posts 9-month profit attributable of HK$‍2.04​ bln

* 9-month profit attributable HK$‍2.04​ billion versus HK$1.57 billion

BRIEF-CSPC Pharmaceutical Group updates on approvals ​of granted clinical trial

* Group's "HA121-28" and "alprostadil liposome injection" were granted clinical trial approvals ​

BRIEF-CSPC Pharmaceutical Group ‍to issue 189 mln placing shares at HK$12.44 per share​

* ‍shall issue 189 million placing shares at placing price of hk$12.44 per share​

BRIEF-CSPC Pharmaceutical Group updates on trading halt

* ‍seeks trading halt pending release of announcement regarding placing of new shares under general mandate​ Source text for Eikon: Further company coverage:

BRIEF-CSPC Pharmaceutical says‍ trading in shares of co has been halted

* ‍Trading in shares of co has been halted at 9:08 a.m. on oct 12 Source text for Eikon: Further company coverage:

Select another date: